Clean Science And Technology Limited (CLEAN)

Loading page…

Clean Science And Technology Limited (CLEAN) · mywealthgrid

About

Clean Science operates in specialty chemicals within the Materials/Chemicals & Petrochemicals sector. Market cap of ₹8,732 Cr with quarterly revenues of 185-268 ₹Cr; operating margins average 37.12% (recent range 32-45%), zero debt (D/E 0), and consistent profitability across recent quarters.

Face value: ₹1

Market cap

₹8,536 Cr

P/E

36.6×

P/B

5.4×

Dividend yield

0.7%

ROE

15.3%

ROCE

20.2%

Debt / equity

OPM

37.1%

EPS (TTM)

₹21.9

Book value

₹149.0

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

P/E of 37.49 against 1-year return of -31.34% suggests market skepticism on growth relative to valuation; verify near-term earnings momentum and management capital plans
Operating margin volatility (32.86% to 44.7% across recent quarters) reveals exposure to cost inflation or product-mix variability; verify margin drivers and sustainability
Specialty chemicals sector faces typical raw material cost cycles and competitive pressure; verify CLEAN's sourcing resilience and customer concentration
Five dividend declarations since Aug 2024 with no disclosed growth capex plans; verify whether dividend focus constrains reinvestment for volume expansion

Generated analysis · source review pending

Growth drivers

Operating margins sustained at 32-46% (37.12% avg) demonstrate pricing resilience in specialty chemicals; revenue growth requires volume expansion—verify capacity utilization and demand drivers in served end-markets
Zero debt (D/E 0) provides balance sheet flexibility for growth deployment; verify if management plans capex for capacity, market expansion, or acquisitions vs. maintaining dividend distributions
Consistent EPS (4.3-6.9 over recent quarters) and profitability indicate scalable business model; growth depends on capital allocation shift toward organic or inorganic expansion

Generated analysis · source review pending

1,283 historical price candles were omitted because the exchange source has not been verified.

₹803.1+3.5%1Y

Quick read

rule-based

Pros

+Strong return on equity of 19.2% (3-yr avg)
+High return on capital employed of 25.2%
+Healthy operating margin of 37.1%
+Almost debt-free (debt/equity 0)
+Comfortable interest coverage of 885.8×
+Dividend payout of 27.4% of profit

Cons

−Promoter holding fell 23.7 pts over the last year

Research score

Structured signal from quality, growth, valuation and momentum.

46/100

Business quality: 78
Growth: 21

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Part ofNIFTY SMALLCAP 250 NIFTY MIDSMALLCAP 400 NIFTY 500 NIFTY TOTAL MARKET

Screen this industry

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	512	685	936	791	967	957
COGS	124	225	326	277	351	357
Gross profit	389	460	610	514	616	599
	130	160	208	182	228	244
	259	300	402	332	388	355
OPM %	50.5%	43.8%	43%	42%	40.1%	37.1%
Depreciation	17	25	36	46	69	78
Interest	0	0	0	1	0	0
	26	30	30	41	39	33
Profit before tax	267	305	396	327	357	310
Tax	69	76	100	82	92	80
Tax %	25.8%	25%	25.4%	25.3%	25.9%	25.8%
	198	229	295	244	264	230
PAT margin %	38.7%	33.4%	31.5%	30.8%	27.4%	24%
EPS (₹)	18.7	21.5	27.8	23	24.9	21.6
EPS adjusted (₹)	18.7	21.5	27.8	23	24.9	21.6
	0%	15.1%	18%	21.8%	24.1%	27.8%
Annual report	—	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	1	11	11	11	11	11	11
Reserves	—	529	758	999	1,193	1,406	1,573
Minority interest	—	0	—	—	—	—	—
	—	0	0	0	0	0	0
	—	120	156	142	193	191	199
Total equity & liabilities	—	660	925	1,152	1,396	1,608	1,783
	166	186	296	423	599	715	760
CWIP	—	55	44	20	57	30	118
Investments	—	232	191	390	376	381	405
	—	187	394	318	363	482	500
Total assets	—	660	925	1,152	1,396	1,608	1,783

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	75.9%	67.2%	65.2%	65%	63.7%	62.7%
EBITDA margin %	50.5%	43.8%	43%	42%	40.1%	37.1%
EBIT margin %	47.2%	40.1%	39.1%	36.2%	33%	29%
PAT margin %	38.7%	33.4%	31.5%	30.8%	27.4%	24%
Working capital
Receivable days	53	82	57	76	77	79
Inventory days	156	143	122	163	156	157
Payable days	180	166	90	143	103	118
NWC days	29	59	89	96	129	118
Leverage
Current ratio	3.87	4.15	5.46	4.12	5.14	5.01
Debt to EBITDA	0	0	0	0	0	0
Debt to equity	0	0	0	0	0	0
Interest coverage	2,971	2,033	1,979.2	352.1	850.4	885.8
Asset turnover	0.78	0.74	0.81	0.57	0.6	0.54
Return ratios
Return on assets %	30.1%	24.7%	25.6%	17.5%	16.4%	12.9%
Return on capital employed %	47.9%	45.3%	43.4%	28.8%	26.6%	20.2%
Return on equity %	36.8%	29.7%	29.2%	20.3%	18.7%	14.5%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	74.98%	74.98%	74.98%	74.98%	74.97%	74.97%	74.97%	74.97%	50.97%	50.96%	51.29%	51.29%
	6%	5.92%	5.88%	6.06%	5.83%	5.98%	6.07%	6.21%	11.14%	10%	13.39%	13.37%
	5.23%	5.14%	5.04%	4.55%	4.77%	5.46%	5.76%	5.92%	18.98%	19.76%	17.14%	16.23%
	0%	0%	0%	0%	0%	0%	0%	0%	0%	0.01%	0.01%	0.01%
	13.79%	13.96%	14.1%	14.41%	14.43%	13.59%	13.2%	12.9%	18.91%	19.27%	18.17%	19.1%
No. of shareholders	—	—	—	—	—	—	—	—	2,39,974	2,43,606	2,37,113	2,41,947

Promoter holding down 23.69 percentage points since Sep 2023.

68 deals · 18 Aug 2021 – 6 Aug 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
6 Aug 2026	SUNDARAM MUTUAL FUND	Bulk	BSE	Buy	7,88,457	₹770.00	₹60.71 Cr
2 Feb 2026	AMANSA HOLDING PRIVATE LTD.	Bulk	NSE	Buy	11,79,506	₹791.84	₹93.40 Cr
21 Aug 2025	SPARK INSTITUTIONAL EQUITIES PRIVATE LIMITED	Bulk	BSE	Buy	3,22,37,036	₹1,078.00	₹3,475.15 Cr
21 Aug 2025	SPARK INSTITUTIONAL EQUITIES PRIVATE LIMITED	Bulk	BSE	Sell	3,22,15,200	₹1,078.57	₹3,474.63 Cr
21 Aug 2025	ASHA ASHOK BOOB	Bulk	BSE	Sell	70,00,000	₹1,077.57	₹754.30 Cr
21 Aug 2025	ASHOK RAMNARAYAN BOOB	Bulk	BSE	Sell	49,84,800	₹1,078.03	₹537.38 Cr
21 Aug 2025	SHRADHA ANISH KARIWALA	Bulk	BSE	Sell	32,05,986	₹1,077.63	₹345.49 Cr
21 Aug 2025	IRAGE BROKING SERVICES LLP	Bulk	NSE	Sell	30,96,252	₹1,103.95	₹341.81 Cr
21 Aug 2025	IRAGE BROKING SERVICES LLP	Bulk	BSE	Buy	30,52,145	₹1,102.32	₹336.44 Cr
21 Aug 2025	PARTH ASHOK MAHESHWARI	Bulk	BSE	Sell	30,00,000	₹1,078.81	₹323.64 Cr

1–10 of 68

1 / 7

Mr. Pradeep Ramwilas RathiNon-Executive - Non Independent Director-Chairperson
Mr. Ashok Ramnarayan BoobExecutive Director
Mr. Siddhartha Ashok SikchiExecutive Director-MD
Mr. Krishnakumar Ramnarayan BoobExecutive Director
Mr. Keval Navinchandra DoshiNon-Executive - Independent Director
Mr. Raj KamalNon-Executive - Independent Director
Ms. Pallavi Pratap GokhaleNon-Executive - Independent Director
Mr. Sanjay ParnerkarChief Financial Officer
Ms. Ruchita VijCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 9 fund houses

Held by these funds

5.47%

of the company's equity

All mutual funds

12%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

32 schemes · 9 fund houses

		Shares
SMALL CAP FUND	Nippon India Mutual Fund	30.91 L	254.36	0.31%	2.908%	-0
Multi Cap FundNEW	Nippon India Mutual Fund	14.09 L	115.96	0.21%	1.326%	—
Comma Fund	SBI Mutual Fund	3.94 L	32.46	2.62%	0.371%	-0
MNC Fund	SBI Mutual Fund	3 L	24.69	0.37%	0.282%	-2.15 L
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	2.22 L	18.31	2.31%	0.209%	-0
SMALL CAP FUND	Bank of India Mutual Fund	89,000	7.32	0.22%	0.084%	-0
Nifty Smallcap 250 Index Fund	Nippon India Mutual Fund	76,059	6.26	0.18%	0.072%	+930
Nifty Smallcap250 Quality 50 Index Fund	DSP Mutual Fund	53,298	4.39	1.39%	0.05%	-49

1–8 of 32

1 / 4

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

9

Final dividend4 Sept 2026 · ex-date₹4
Interim dividend6 Feb 2026 · ex-date₹2
Final dividend4 Sept 2025 · ex-date₹4
Interim dividend7 Feb 2025 · ex-date₹2
Final dividend29 Aug 2024 · ex-date₹3
Interim dividend12 Feb 2024 · ex-date₹2
Final dividend3 Aug 2023 · ex-date₹3
Interim dividend10 Feb 2023 · ex-date₹2
Final dividend29 Jul 2022 · ex-date₹3.25

1

Board meeting to consider results1 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

76 announcementsExport CSV

30 Sept 2026, 4:40 pmCompany Update

Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Search And Seizure Proceedings By Goods And Services Tax (GST) Department

Loading announcements…

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	75.9%	67.2%	65.2%	65%	63.7%	62.7%
EBITDA margin %	50.5%	43.8%	43%	42%	40.1%	37.1%
EBIT margin %	47.2%	40.1%	39.1%	36.2%	33%	29%
PAT margin %	38.7%	33.4%	31.5%	30.8%	27.4%	24%
Working capital
Receivable days	53	82	57	76	77	79
Inventory days	156	143	122	163	156	157
Payable days	180	166	90	143	103	118
NWC days	29	59	89	96	129	118
Leverage
Current ratio	3.87	4.15	5.46	4.12	5.14	5.01
Debt to EBITDA	0	0	0	0	0	0
Debt to equity	0	0	0	0	0	0
Interest coverage	2,971	2,033	1,979.2	352.1	850.4	885.8
Asset turnover	0.78	0.74	0.81	0.57	0.6	0.54
Return ratios
Return on assets %	30.1%	24.7%	25.6%	17.5%	16.4%	12.9%
Return on capital employed %	47.9%	45.3%	43.4%	28.8%	26.6%	20.2%
Return on equity %	36.8%	29.7%	29.2%	20.3%	18.7%	14.5%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Gujarat Fluorochemicals LimitedFLUOROCHEMFLUOROCHEM	₹47,713 Cr	₹49,912 Cr	₹5,303 Cr	₹1,375 Cr	25.8%	₹615 Cr	11.5%	11.1%	7.6%	401
Navin Fluorine International LimitedNAVINFLUORNAVINFLUOR	₹41,740 Cr	₹42,967 Cr	₹3,634 Cr	₹1,232 Cr	32.6%	₹790 Cr	20%	21.6%	20.1%	61
Aether Industries LimitedAETHERAETHER	₹22,161 Cr	₹22,603 Cr	₹1,224 Cr	₹384 Cr	31.3%	₹235 Cr	19.8%	13.2%	9.4%	330
Atul LimitedATULATUL	₹17,231 Cr	₹17,411 Cr	₹6,643 Cr	₹1,189 Cr	16.4%	₹704 Cr	11%	14.1%	11.5%	70
Aarti Industries LimitedAARTIINDAARTIIND	₹16,869 Cr	₹21,790 Cr	₹9,012 Cr	₹1,337 Cr	14.1%	₹531 Cr	5.1%	8.8%	7.3%	54
Fine Organic Industries LimitedFINEORGFINEORG	₹15,752 Cr	₹15,797 Cr	₹2,472 Cr	₹535 Cr	20.4%	₹438 Cr	17.6%	21.6%	16.8%	113
Basf India LimitedBASFBASF	₹14,796 Cr	₹14,796 Cr	₹16,177 Cr	₹952 Cr	4.4%	₹643 Cr	2.8%	14%	11.1%	40
Privi Speciality Chemicals LimitedPRIVISCLPRIVISCL	₹13,970 Cr	₹14,980 Cr	₹2,671 Cr	₹666 Cr	25.2%	₹342 Cr	12.4%	27.7%	25.2%	158
Sudeep Pharma LimitedSUDEEPPHRMSUDEEPPHRM	₹13,546 Cr	₹13,694 Cr	₹676 Cr	₹233 Cr	34.6%	₹133 Cr	27.1%	31.1%	25.2%	366
Anupam Rasayan India LimitedANURASANURAS	₹13,243 Cr	₹15,058 Cr	₹2,535 Cr	₹563 Cr	22.2%	₹175 Cr	9.4%	9.1%	5.5%	377
Vinati Organics LimitedVINATIORGAVINATIORGA	₹12,528 Cr	₹12,528 Cr	₹2,381 Cr	₹665 Cr	29.4%	₹448 Cr	19.9%	18.8%	14.9%	152
Elantas Beck India LimitedELANTASELANTAS	₹10,644 Cr	₹10,644 Cr	₹778 Cr	₹147 Cr	20.3%	₹136 Cr	17.4%	20.6%	15.8%	70

Date	Category	Subject	Filing
30 Sept 2026, 4:40 pm	Company Update General	Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Search And Seizure Proceedings By Goods And Services Tax (GST) Department	PDF
12 Sept 2026, 5:18 pm	Corp. Action Dividend Updates	Announcement under Regulation 30 (LODR)-Dividend Updates	PDF
12 Sept 2026, 5:14 pm	Company Update Change in Directorate	Announcement under Regulation 30 (LODR)-Change in Directorate	PDF
12 Sept 2026, 5:09 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
12 Sept 2026, 5:05 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Outcome of AGM	PDF
31 Aug 2026, 5:53 pm	Company Update Allotment of ESOP / ESPS	Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS	PDF
20 Aug 2026, 4:53 pm	Company Update General	Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Incorporation Of Clean Science International B.V. (Wholly Owned Subsidiary Of Clean Fino-Chem Limited)	PDF
19 Aug 2026, 11:37 am	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	193	127	279	237	214	275
	-187	-79	-270	-186	-152	-203
	-6	-0	-55	-53	-53	-64
Net cash flow	0	49	-45	-2	10	8
Free cash flow	108	-12	96	5	72	73
CFO / Operating profit %	74.5%	42.4%	69.5%	71.4%	55.2%	77.3%

Clean Science And Technology Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

9

1

Announcements

9

1

Not in the F&O segment

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Compounded sales growth

Compounded profit growth

Return on equity

Clean Science And Technology Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

Dividends9

Board meetings1

Announcements

Dividends9

Board meetings1

Ratio timeline

Not in the F&O segment

Quarterly record

Bulk & block deals

Board and management

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

9

1

9

1